AKI Management: Diuretics

Diuretics play a significant role in managing fluid overload and related complications, particularly in critically ill patients with acute kidney injury (AKI). Despite their widespread use in intensive care units (ICUs), there remain uncertainties regarding their optimal use, especially in the context of AKI. This review explores the pharmacology, indications, and practical considerations for using diuretics in critically ill patients with AKI. Diuretics act by blocking sodium reabsorption in renal tubules, leading to natriuresis and water loss. Loop diuretics are commonly prescribed in the ICU due to their potent effect on sodium reabsorption. Other classes of diuretics, such as thiazides and aldosterone antagonists, may be used in specific situations. The main indication for diuretic use in AKI is fluid overload, with additional considerations for electrolyte abnormalities and prognostication. Strategies to minimize fluid overload, including diuretic use and fluid restrictive protocols, have been investigated, but their impact on outcomes remains uncertain. While diuretics are commonly used to assess tubular function and aid in AKI prognostication, their role in preventing AKI or promoting recovery is limited. Proper dosing, administration, and monitoring of diuretics are essential to avoid adverse effects and optimize therapeutic outcomes. Overall, diuretics should be judiciously used in critically ill patients with AKI, focusing on established indications such as fluid overload management and prognostication.